The company, called Meenta, has developed an algorithm that finds researchers with similar projects to bundle together to assign to a sequencing machine that's filling up with experiments. This way, CEO and co-founder Gabor Bethlendy tells Wired, more researchers would have access to sequencing machines.
Wired says that there currently are some 3,000 sequencers in the US and there between $80,000 to $985,000, but it notes that Illumina recently unveiled a $20,000 iSeq machine. Weill Cornell Medicine's Christopher Mason told GenomeWeb in January that he was excited about that machine because it underscored the possibility of "home-based sequencing."
Meenta is also moving beyond offering only sequencing-matching services, Wired says, as it has an agreement with HarkerBIO, a company that offers protein structure analysis, and wants to offer a full workflow. "I think scientists should be able to create experiments in the cloud without ever owning the instruments," Bethlendy adds.